M Pharmaceutical Inc Aktie Canadian Securities Exchange
Aktien
CA55346E2050
Biotechnologie
Umsatz 2018 | 0.75 1.03 0.68 | Umsatz 2019 | 0.71 0.97 0.64 | Marktwert | 3.53 Mio. 4.82 Mio. 3.19 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -6.84 Mio. -4.53 Mio. | Nettoergebnis 2019 | -1 Mio. -1.37 Mio. -905’720 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 436’254 288’916 | Nettoschuld 2019 | 847’693 1.16 Mio. 767’773 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
+25.69% | 47.9 Mrd. | |
+47.19% | 41.42 Mrd. | |
-3.46% | 40.7 Mrd. | |
-6.20% | 28.92 Mrd. | |
+9.17% | 25.55 Mrd. | |
-20.42% | 19.27 Mrd. | |
+0.17% | 12.15 Mrd. | |
+28.07% | 12.14 Mrd. | |
-1.24% | 11.99 Mrd. |